Wadi Jeddah to Launch $10 Million Venture Capital Fund to Support Startups in Saudi Arabia

Wadi Jeddah, the investment arm of King Abdulaziz University, is preparing to launch a $10 million venture capital fund in early 2027 to expand startup financing and accelerate the commercialization of university-based research. The fund will target startups inside and outside the Wadi Jeddah ecosystem, with a primary focus on Saudi companies across the Kingdom while remaining open to international firms seeking entry into the Saudi market.

"The fund’s role will not be measured solely by the number of companies it finances, but also by its ability to bridge the funding gap between innovation and commercial investment," the institution said, outlining the fund’s mission to help technology- and research-driven startups move from development to sustainable revenue and growth.

Fund structure and complementary programs

Wadi Jeddah plans to seed part of the fund’s capital itself and to attract additional commitments from private-sector investors and investment institutions to strengthen financing capacity and expand the pool of investable startups. Management has signalled ambitions to grow and potentially double the fund’s size over the next decade to allow for follow-on investments in high-growth companies.

Alongside the planned $10 million vehicle, Wadi Jeddah continues to operate its innovation incubator. The incubator recently selected 10 startups for its program and allocated a total of SAR1 million in support—equivalent to SAR100,000 per company. The cohort includes ventures working in artificial intelligence, health and biotechnology, food technology, smart cities, and sustainability, with participating companies receiving incubation, mentoring, business-model development and preparation for future funding rounds.

From campus research to commercial products

The fund is positioned as part of a broader strategy to move university research into market-ready products, particularly in pharmaceuticals and knowledge-based technologies. Teryaq Pharmaceutical Industries is cited as a working example: the company was established with capital of SAR500,000 based on research from the Faculty of Pharmacy at King Abdulaziz University and began producing its first products roughly a year ago. Teryaq’s portfolio has since expanded to 13 pharmaceutical products available in the Saudi market, and the company has plans to develop treatments for respiratory and gastrointestinal diseases as well as medical supplements.

• Target sectors for the fund include artificial intelligence, biotechnology, pharmaceuticals, smart cities, future mobility, food manufacturing, advanced manufacturing and advanced materials.
• The fund will consider investments in international companies that aim to enter the Saudi market, adding a cross-border dimension to its mandate.

Outlook

Wadi Jeddah frames the $10 million fund as more than a capital pool: it is intended to act as an investment bridge linking scientific research, venture capital and commercial markets. By focusing on the so-called "Valley of Death"—the stage where many ventures fail to convert technology or prototypes into viable businesses—the fund aims to provide patient capital and operational support to research-driven startups that require longer development timelines.

If Wadi Jeddah succeeds in attracting co-investors and scaling the fund as planned, the initiative could increase the number of university-linked ventures reaching commercial scale and attract international technology and capital into Saudi Arabia. Success will be measured by the fund’s ability to convert research into scalable businesses that generate economic value and meet market needs.